Why Brand Companies Launch Authorized Generics: The Strategy Explained
Discover why pharmaceutical giants launch authorized generics. This guide explains the strategy behind protecting revenue, exploiting regulatory loopholes, and maintaining market share during patent cliffs.
How Brand Manufacturers Produce Their Own Generic Versions
Brand-name drug companies often produce their own generic versions to retain market share after patents expire. These authorized generics are identical to the original drug but sold under a different label, offering a middle-ground pricing strategy that preserves revenue while appearing to lower costs.